Am I Natty or Not (as an MD)?

The video opens by questioning whether the Anabolic Doc is “natty,” while challenging how that word is used online. Rather than leaning on accusations, the presenter defines “natural” as a spectrum once testosterone replacement enters the picture. A long training history is described beginning in early adolescence, with years of lifting that built strength before hormones. Early curiosity about steroids is acknowledged, including the reality that access and temptation appear long before maturity. Genetics and consistency are emphasized as real contributors, because progress can be dramatic without pharmacology for some lifters. At the same time, physique claims are framed as something that deserves clear context, not gossip or vague insinuations. The introduction sets a tone of transparency, encouraging evidence and specifics over rumor-driven conclusions.

Attention shifts to androgen history and how testosterone use was approached across different life stages. TRT-level dosing is contrasted with aggressive stacking, highlighting that intent, dose, and monitoring separate very different risks. Several compounds are named from prior experimentation, including deca, equipoise, and D-ball layered over testosterone. A health scare around age forty becomes a turning point, with panic attacks and anxiety prompting a more serious reassessment. Blood pressure is mentioned as a concrete signal, with readings around 140 over 90 raising concern during heavier bodyweight phases. Laboratory and imaging markers are referenced as additional feedback, including creatinine near 1.5 and a calcium score of 15. Lipid changes are treated as part of the same risk conversation, reinforcing that denial is less useful than measurement.

Visible side effects are discussed to show that decisions often involve tradeoffs beyond aesthetics, including androgen-related hair loss. Estrogen conversion is framed as a common issue on testosterone, especially when dosing drifts above what replacement truly requires. Fertility is addressed in practical terms, noting that children are already part of the story and hCG is used in small amounts. In contrast, additional agents are avoided, with Clomid and tamoxifen explicitly described as not part of the current routine. Training performance is used as context, including a five-hundred-pound bench at forty-seven while bodyweight stayed near 190 to 195. Across the discussion, labs, symptoms, and cardiovascular markers are treated as signals that guide safer long-term choices. The closing takeaway is that transparency plus disciplined monitoring is more honest than claiming every result is purely natural.